Hello Mgoble,
The U.S. market for asthma drugs accounts for approximately half of
the global total (1), and the worldwide asthma therapeutics market is
estimated at over $12.92 billion in 2005 (2), the size of the U.S.
Asthma market can be estimated at US$ 6.46 billion.
(1) ?The world market for asthma drugs is expected to exceed $20
billion by 2010, according to MarketResearch, with the U.S. market
accounting for approximately half of the global total.?
The pharma company launches the world?s first novel combination drug for asthma.
September 12, 2006
http://www.redherring.com/Article.aspx?a=18481&hed=Ranbaxy+Debuts+Asthma+Drug§or=Regions&subsector=Asia
(2) The worldwide asthma therapeutics market is estimated at over
$12.92 billion in 2005 and is expected to grow at a compound annual
rate of 11.2% to reach more than $21.94 billion by 2010.
Asthma Therapeutics
Navigant Consulting, Inc.
February 1, 2005
http://www.marketresearch.com/product/display.asp?productid=1144752&g=1
======================================
From a 2005 article:
Annual sales of asthma drugs in the United States alone exceeds US$4.0
billion and is growing at over 10%.
Source:
Medical News Today
GroPep To Pursue Promising Asthma Drug Following Preclinical Study Results
Asthma / Respiratory News
15 Dec 2005
http://www.medicalnewstoday.com/medicalnews.php?newsid=34974
======================================
Additional information that might interest you:
The Respiratory market is the fourth largest therapeutic category by
sales and generated nearly US$32.4 billion (+8% YoY) in 2005.
Sales grew steadily in the US, which accounted for around 54% of
global respiratory sales, driven by growth in Advair,
GlaxoSmithKline?s leading combination therapy for the treatment of
asthma/COPD and Merck?s Singulair for the treatment of asthma and
allergic rhinitis.?
(?)
?Over 50% of respiratory drug sales were spent on asthma and chronic
obstructive pulmonary disease (COPD), the remainder is spent on other
respiratory diseases such as allergic rhinitis, coughs and colds,
cystic fibrosis and pneumonia. We estimate that the asthma market was
worth US$13.5 billion in 2005 and dominated by the sale of inhaled
corticosteroids. We forecast that the current market for COPD drug
therapy is worth nearly US$4.4 billion per annum and it is predicted
to increase to nearly US$7 billion by 2010.?
?Asthma affects over 100 million people worldwide. Approximately
5%-10% of adults and 10%-15% of children suffer from asthma globally
and it continues to grow at around 5%-6% per annum. Over 18 million
Americans have asthma, but only around 60% of US sufferers are
treated. US asthma prevalence rates have risen by almost 50% in the
ten years ending 1994 and are expected to increase by 20%-50% every
ten years.?
Espicom Business Intelligence
May 19th, 2006
http://www.espicom.com/prodcat.nsf/Product_ID_Lookup/00001274?OpenDocument
======================================
Search terms:
Market for asthma medications OR drugs OR medications billion
Asthma drug market United States billion
I hope the information provided is helpful!
Best regards,
Bobbie7 |
Clarification of Answer by
bobbie7-ga
on
03 Dec 2006 09:37 PST
The American Lung Association has recently published an Asthma Medications Chart.
------------------------------------------
Long-Term Control Medications
------------------------------------------
Generic Name Brand Name
------------------------------------------
formoterol fumarate Foradil Aerolizer
salmeterol xinofate Serevent Diskus
Budesonide + formeterol
Fumerate Symbicort
Ipratropium bromide
+ albuterol sulfate Combivent, Duoneb
flucticasone propionate
+ salmeterol xinofate Advair Diskus
Theophylline Aerolate III, Aerolate JR
Aerolate SR, Choledyl SA
Elixophyllin, Quibron- T
Quibron - T/SR, Slo-bid
Slo-Phyllin, Theo-24
Theochron, Theo-Dur, Theolair
Theolair SR, T-Phyl, Uni-Dur
Uniphyl,
beclomethasone
diaproprionate QVAR 40mg, QVAR 80mg
budesonide Pulmicort Respules
Pulmicort Turbuhaler
Flunisolide AeroBid, Aerospan HFA
fluticasone proprionate Flovent, Flovent Diskus
Flovent HFA
mometasone furoate Asthmanex
triamcinolone Azmacort
cromolyn sodium Intal
nedocromil sodium Tilade
zafirlukast Accolate
zileuton Zyflo
montelukast Singulair
------------------------------------------
------------------------------------------
Quick Relief Medicines
------------------------------------------
Generic Name Brand Name
------------------------------------------
albuterol Accuneb
Proventil HFA
Ventolin HFA
albuterol sulfate ProAir HFA
Proventil Repetabs
VoSpire ER
pirbuterol acetate Maxair
terbutaline Sulfate Brethine (tabs only)
levalbuterol Xopenex
Levalbuterol tartrate Xopenex HFA
Ipratropium bromide Atrovent
------------------------------------------
American Lung Association: October 2006
http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=263990
|
